NDC 70842-140 – Orbactiv

Oritavancin 400 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC70842-140

Product details

Brand name
Orbactiv
Generic name
Oritavancin
Labeler
Melinta Therapeutics, LLC
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
NDA · NDA206334
Marketed since
September 1, 2014
Listing expires
December 31, 2026
Pharmacologic class
Lipoglycopeptide Antibacterial

Active ingredients

Uses, dosage, side effects and warnings for Orbactiv →

Package NDC codes (1)

Package NDCDescriptionSince
70842-140-033 VIAL, GLASS in 1 CARTON (70842-140-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01)Sep 1, 2014